{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:01:09Z","timestamp":1778842869412,"version":"3.51.4"},"reference-count":49,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.3892\/mmr.2017.7664","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T06:39:04Z","timestamp":1506667144000},"page":"8530-8536","source":"Crossref","is-referenced-by-count":8,"title":["MicroRNA-320 targets mitogen-activated protein kinase 1 to inhibit cell proliferation and invasion in epithelial ovarian cancer"],"prefix":"10.3892","volume":"16","author":[{"given":"Yongqian","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,9,29]]},"reference":[{"key":"key20180108005301_b1-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"key20180108005301_b2-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"key20180108005301_b3-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00428-012-1203-5","article-title":"Ovarian carcinomas: Five distinct diseases with different origins, genetic alterations, and clinicopathological features","volume":"460","author":"Prat","year":"2012","journal-title":"Virchows Arch"},{"key":"key20180108005301_b4-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fonc.2014.00143","article-title":"Regulation of metastasis by microRNAs in ovarian cancer","volume":"4","author":"Wang","year":"2014","journal-title":"Front Oncol"},{"key":"key20180108005301_b5-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2217\/17455057.4.1.27","article-title":"Biomarker discovery in ovarian cancer","volume":"4","author":"Tung","year":"2008","journal-title":"Womens Health (Lond)"},{"key":"key20180108005301_b6-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"key20180108005301_b7-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/wrna.121","article-title":"Posttranscriptional upregulation by microRNAs","volume":"3","author":"Vasudevan","year":"2012","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"key20180108005301_b8-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat Rev Genet"},{"key":"key20180108005301_b9-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"e0159601","DOI":"10.1371\/journal.pone.0159601","article-title":"miR-9 acts as an oncomiR in prostate cancer through multiple pathways that drive tumour progression and metastasis","volume":"11","author":"Seashols-Williams","year":"2016","journal-title":"PLoS One"},{"key":"key20180108005301_b10-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fphar.2016.00271","article-title":"miR-200c regulation of metastases in ovarian cancer: Potential role in epithelial and mesenchymal transition","volume":"7","author":"Sulaiman","year":"2016","journal-title":"Front Pharmacol"},{"key":"key20180108005301_b11-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"40038","DOI":"10.18632\/oncotarget.9480","article-title":"MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1","volume":"7","author":"Xiao","year":"2016","journal-title":"Oncotarget"},{"key":"key20180108005301_b12-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.yexcr.2016.09.021","article-title":"miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1\/fibronectin","volume":"348","author":"Das","year":"2016","journal-title":"Exp Cell Res"},{"key":"key20180108005301_b13-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.yexcr.2016.09.010","article-title":"Overexpression of microRNA-1288 in oesophageal squamous cell carcinoma","volume":"348","author":"Gopalan","year":"2016","journal-title":"Exp Cell Res"},{"key":"key20180108005301_b14-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.biopha.2016.07.038","article-title":"Inhibition of microRNA-383 has tumor suppressive effect in human epithelial ovarian cancer through the action on caspase-2 gene","volume":"83","author":"Liu","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"key20180108005301_b15-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.2147\/OTT.S105198","article-title":"MiR-126 regulates proliferation and invasion in the bladder cancer BLS cell line by targeting the PIK3R2-mediated PI3K\/Akt signaling pathway","volume":"9","author":"Xiao","year":"2016","journal-title":"Onco Targets Ther"},{"key":"key20180108005301_b16-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.3892\/ol.2016.4953","article-title":"Tumor-suppressing effects of microRNA-429 in human renal cell carcinoma via the downregulation of Sp1","volume":"12","author":"Wu","year":"2016","journal-title":"Oncol Lett"},{"key":"key20180108005301_b17-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3892\/ijmm.2016.2775","article-title":"MicroRNA-16 inhibits the proliferation, migration and invasion of glioma cells by targeting Sal-like protein 4","volume":"38","author":"Zhou","year":"2016","journal-title":"Int J Mol Med"},{"key":"key20180108005301_b18-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.biopha.2016.08.058","article-title":"MicroRNA-421 inhibits breast cancer metastasis by targeting metastasis associated 1","volume":"83","author":"Pan","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"key20180108005301_b19-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.cell.2009.02.005","article-title":"MicroRNAs and cancer: Short RNAs go a long way","volume":"136","author":"Ventura","year":"2009","journal-title":"Cell"},{"key":"key20180108005301_b20-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"38612","DOI":"10.18632\/oncotarget.9572","article-title":"MicroRNA-320a inhibits breast cancer metastasis by targeting metadherin","volume":"7","author":"Yu","year":"2016","journal-title":"Oncotarget"},{"key":"key20180108005301_b21-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1158\/1538-7445.AM2015-2719","article-title":"MicroRNA-320a inhibits proliferation and invasion of breast cancer cells by targeting RAB11A","volume":"5","author":"Wang","year":"2015","journal-title":"Am J Cancer Res"},{"key":"key20180108005301_b22-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"29275","DOI":"10.18632\/oncotarget.8676","article-title":"MiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"key20180108005301_b23-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/carcin\/bgt378","article-title":"miR-320a suppresses colorectal cancer progression by targeting Rac1","volume":"35","author":"Zhao","year":"2014","journal-title":"Carcinogenesis"},{"key":"key20180108005301_b24-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"11269","DOI":"10.1007\/s13277-014-2283-4","article-title":"MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R","volume":"35","author":"Guo","year":"2014","journal-title":"Tumour Biol"},{"key":"key20180108005301_b25-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.3892\/mmr.2015.3657","article-title":"MicroRNA-320 inhibits cell proliferation in glioma by targeting E2F1","volume":"12","author":"Sun","year":"2015","journal-title":"Mol Med Rep"},{"key":"key20180108005301_b26-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1007\/s11033-014-3110-0","article-title":"MiR-320a down-regulation mediates bladder carcinoma invasion by targeting ITGB3","volume":"41","author":"Shang","year":"2014","journal-title":"Mol Biol Rep"},{"key":"key20180108005301_b27-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20180108005301_b28-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.12659\/MSM.893528","article-title":"HOTAIR interacting with MAPK1 regulates ovarian cancer skov3 cell proliferation, migration, and invasion","volume":"21","author":"Yiwei","year":"2015","journal-title":"Med Sci Monit"},{"key":"key20180108005301_b29-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"13748","DOI":"10.3390\/ijms140713748","article-title":"KRAS and MAPK1 gene amplification in type II ovarian carcinomas","volume":"14","author":"Rahman","year":"2013","journal-title":"Int J Mol Sci"},{"key":"key20180108005301_b30-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.1038\/onc.2010.352","article-title":"MicroRNA dysregulation in gastric cancer: A new player enters the game","volume":"29","author":"Wu","year":"2010","journal-title":"Oncogene"},{"key":"key20180108005301_b31-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s13277-013-0940-7","article-title":"MicroRNAs in osteosarcoma: Diagnostic and therapeutic aspects","volume":"34","author":"Miao","year":"2013","journal-title":"Tumour Biol"},{"key":"key20180108005301_b32-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"8931","DOI":"10.1007\/s13277-015-4771-6","article-title":"Down-regulation of miR-320 associated with cancer progression and cell apoptosis via targeting Mcl-1 in cervical cancer","volume":"37","author":"Zhang","year":"2016","journal-title":"Tumour Biol"},{"key":"key20180108005301_b33-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3892\/mmr.2016.5370","article-title":"MicroRNA-320 was downregulated in non-small cell lung cancer and inhibited cell proliferation, migration and invasion by targeting fatty acid synthase","volume":"14","author":"Lei","year":"2016","journal-title":"Mol Med Rep"},{"key":"key20180108005301_b34-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3892\/ol.2014.2298","article-title":"miR-320a is an independent prognostic biomarker for invasive breast cancer","volume":"8","author":"Yang","year":"2014","journal-title":"Oncol Lett"},{"key":"key20180108005301_b35-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/0973-1482.191635","article-title":"Inhibitory roles of miR-320 in osteosarcoma via regulating E2F1","volume":"12","author":"Wu","year":"2016","journal-title":"J Cancer Res Ther"},{"key":"key20180108005301_b36-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4251\/wjgo.v8.i7.532","article-title":"MicroRNA-320 family is downregulated in colorectal adenoma and affects tumor proliferation by targeting CDK6","volume":"8","author":"Tadano","year":"2016","journal-title":"World J Gastrointest Oncol"},{"key":"key20180108005301_b37-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.bbrc.2016.04.069","article-title":"miR-320a regulates cell proliferation and apoptosis in multiple myeloma by targeting pre-B-cell leukemia transcription factor 3","volume":"473","author":"Lu","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108005301_b38-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12943-015-0344-y","article-title":"MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3","volume":"14","author":"Sun","year":"2015","journal-title":"Mol Cancer"},{"key":"key20180108005301_b39-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1016\/j.febslet.2014.08.021","article-title":"MicroRNA-320a inhibits cell proliferation, migration and invasion by targeting BMI-1 in nasopharyngeal carcinoma","volume":"588","author":"Qi","year":"2014","journal-title":"FEBS Lett"},{"key":"key20180108005301_b40-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"27641","DOI":"10.1038\/srep27641","article-title":"MicroRNA-320a promotes 5-FU resistance in human pancreatic cancer cells","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"key20180108005301_b41-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"8735","DOI":"10.1038\/srep08735","article-title":"MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERR\u03b3","volume":"5","author":"Lu","year":"2015","journal-title":"Sci Rep"},{"key":"key20180108005301_b42-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbrc.2014.11.039","article-title":"miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1","volume":"457","author":"Wan","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108005301_b43-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10456-013-9394-1","article-title":"miR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1","volume":"17","author":"Wu","year":"2014","journal-title":"Angiogenesis"},{"key":"key20180108005301_b44-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1096\/fasebj.9.9.7601337","article-title":"The MAPK signaling cascade","volume":"9","author":"Seger","year":"1995","journal-title":"FASEB J"},{"key":"key20180108005301_b45-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.apjtm.2015.10.004","article-title":"Expression of MAPK1 in cervical cancer and effect of MAPK1 gene silencing on epithelial-mesenchymal transition, invasion and metastasis","volume":"8","author":"Li","year":"2015","journal-title":"Asian Pac J Trop Med"},{"key":"key20180108005301_b46-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.leukres.2015.01.016","article-title":"Overexpression of survivin via activation of ERK1\/2, Akt, and NF-\u03baB plays a central role in vincristine resistance in multiple myeloma cells","volume":"39","author":"Tsubaki","year":"2015","journal-title":"Leuk Res"},{"key":"key20180108005301_b47-mmr-16-06-8530","first-page":"608","article-title":"Overexpression of Raf-1 and ERK1\/2 in sacral chordoma and association with tumor recurrence","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"key20180108005301_b48-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.18632\/oncotarget.2974","article-title":"Inhibition of ERK1\/2 down-regulates the Hippo\/YAP signaling pathway in human NSCLC cells","volume":"6","author":"You","year":"2015","journal-title":"Oncotarget"},{"key":"key20180108005301_b49-mmr-16-06-8530","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3727\/096504013X13775486749254","article-title":"MiR-378 inhibits progression of human gastric cancer MGC-803 cells by targeting MAPK1 in vitro","volume":"20","author":"Fei","year":"2012","journal-title":"Oncol Res"}],"updated-by":[{"DOI":"10.3892\/mmr.2024.13169","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"record-id":"51371"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T02:33:21Z","timestamp":1570156401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.7664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,29]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,9,29]]},"published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.3892\/mmr.2017.7664"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.7664","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,29]]}}}